The management believes, that on account of ramp-up of existing products, Fermion contract, and potential commercialisation ...

Pace Life Sciences LLC, a U.S.-based contract research, development, and manufacturing organization (CRDMO) and a Division of ...

South Korean biopharma contract manufacturer Celltrion is considering acquiring US manufacturing sites to mitigate President ...

Extension of PLI scheme, more incentives to improve ease of doing business and Prioritizing Research and Development are ...

India's Jubilant Pharmova reported a 51% jump in third-quarter profit on Friday, driven by a strong demand for its drugs with ...

The global cosmetic peptide manufacturing market value is expected to rise from USD 244.2 million in 2024 to USD 411.9 million by 2034. This estimated growth is expected to be driven by a CAGR of 5.4% ...

TUSTIN, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) --. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve ...

Piramal Pharma launched Chlorpromazine Hydrochloride in the US last week. The company reported a 14% growth in its complex ...

Although Lonza posted slightly lower sales than analysts had expected in 2024, the Swiss CDMO suggested in its year-end ...

Experts say budget should focus on expanding the scheme to encompass green energy, advanced textiles, space tech and ...

Small Molecule CMOCDMO MarketThe global small molecule CMO/CDMO market is set for impressive expansion, according to the latest report from Future Market Insights (FMI). The market is projected to ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.